LabAutomation 2006 - SLAS
LabAutomation 2006 - SLAS
LabAutomation 2006 - SLAS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>LabAutomation</strong><strong>2006</strong><br />
10:30 am Wednesday, January 25, <strong>2006</strong> Track 3: High-Throughput Technologies Room: Learning Center<br />
Wyndham Palm Springs Hotel<br />
Zhong Zhong<br />
Co-Author(s)<br />
Cell & Molecular Technologies, Inc.<br />
Natalie Fursov, Cell & Molecular Technologies, Inc.<br />
Phillipsburg, New Jersey<br />
zzhong@cmt-inc.net<br />
Kevin Lee. Sentigen Biosciences<br />
Mark Federici, Roland Tacke, Tom Livelli<br />
Cell & Molecular Technologies, Inc.<br />
Rapid Evaluation of Compounds’ Off-Target Activities Against GPCRs by Tango Assay<br />
System, a Novel Reporter Technology<br />
We have developed a new G-protein coupled receptors (GPCR) profiling panel based on Sentigen Biosciences’ TangoTM Assay System.<br />
Unlike conventional compound selectivity services that utilize biochemical or membrane binding methods, the Tango Assay Profiling system<br />
employs a functional cell-based assay that provides information about efficacy and agonism/antagonism properties. A large cryopreserved<br />
cell bank has been set up in which each cell type expresses one of the 54 selected GPCRs in conjunction with Tango Assay components.<br />
We demonstrated that we can thaw cells from the cell bank to generate custom panels on demand to profile agonism/antagonism<br />
activities of compounds on an array of GPCRs.<br />
Activation of GPCR signaling is in general tightly coupled with subsequent receptor desensitization, a process mediated by the recruitment<br />
of intracellular arrestin proteins to the activated receptor. Tango is a luciferase-based chemiluminescent assay that detects ligand-induced<br />
activation/inactivation of target receptor by quantitatively measuring its interaction with arrestin. The assay design does not depend on<br />
knowledge of the G-protein signaling specificity of the target receptor. In addition, Tango Assay System permits the selective interrogation<br />
of the specific target receptor, and is not affected by signaling mediated by endogenous receptors. The high sensitivity of the assay allows<br />
detection of receptor-ligand interactions without the need of over-expressing target receptor or singaling components. We will present data<br />
to demonstrate that the Tango assays are broadly applicable to all classes of GPCRs. Assays’ homogeneous format and simple workflow<br />
make it ideal for GPCR panel profiling.<br />
10:30 am Monday, January 23, <strong>2006</strong> Track 4: Informatics Room: Madera<br />
Wyndham Palm Springs Hotel<br />
John Davies<br />
Novartis<br />
Cambridge, Massachusetts<br />
john-W.davies@novartis.com<br />
An Holistic Approach to HTS Data Triaging<br />
A number of companies today are trying to offset attrition rates in the drug discovery process by simply widening their pipeline. Companies<br />
are now running more screens with larger collections of compounds than they have ever done before. This is creating a vast amount of<br />
HTS data which often, but not always, feeds into an automated IT analysis platform. At this stage little, if anything, is done to analyze and<br />
triage the entire data set. Even less is done to apply orthogonal data mining methods which can increase SAR knowledge. We will show<br />
a number of different approaches we have employed to analyze large-scale HTS data for the purposes of increasing its intrinsic chemical<br />
and biological information content.<br />
80